Shingles Research Today is a free monthly online journal that collates and summarizes the latest research about Shingles, including details on symptoms, treatment, causes, virus.

Volume 6 (2010), Issue 12 (December)

1. Varicella-zoster virus human ganglionic latency: a current summary.
   J Neurovirol, 16(6): 411-8. [Abstract] [Full-text]
2. Varicella-zoster virus human ganglionic latency: a current summary.
   J Neurovirol, 16(6): 411-8. [Abstract] [Full-text]
3. Varicella-zoster virus human ganglionic latency: a current summary.
   J Neurovirol, 16(6): 411-8. [Abstract] [Full-text]
4. Methodology of the sensitivity analysis used for modeling an infectious disease.
   Vaccine, 28(51): 8132-40. [Abstract] [Full-text]
5. Methodology of the sensitivity analysis used for modeling an infectious disease.
   Vaccine, 28(51): 8132-40. [Abstract] [Full-text]
6. Ocular complications in patients with lung transplants.
   Br J Ophthalmol. [Abstract] [Full-text]
7. Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates.
   J Med Chem. [Abstract] [Full-text]
8. Ocular complications in patients with lung transplants.
   Br J Ophthalmol. [Abstract] [Full-text]
9. Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates.
   J Med Chem. [Abstract] [Full-text]
10. Ocular complications in patients with lung transplants.
    Br J Ophthalmol. [Abstract] [Full-text]
11. Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates.
    J Med Chem. [Abstract] [Full-text]
12. Factors affecting visual outcome in herpes zoster ophthalmicus: a prospective study.
    Clin Experiment Ophthalmol, 38(9): 845-50. [Abstract] [Full-text]
13. Factors affecting visual outcome in herpes zoster ophthalmicus: a prospective study.
    Clin Experiment Ophthalmol, 38(9): 845-50. [Abstract] [Full-text]
14. Factors affecting visual outcome in herpes zoster ophthalmicus: a prospective study.
    Clin Experiment Ophthalmol, 38(9): 845-50. [Abstract] [Full-text]
15. Corticosteroids for preventing postherpetic neuralgia.
    Cochrane Database Syst Rev, 12: CD005582. [Abstract] [Full-text]
16. Keeping our adult patients healthy and active: the role of vaccines across the lifespan.
    Phys Sportsmed, 38(4): 35-47. [Abstract] [Full-text]
17. Necrotizing and Nonnecrotizing Variants of Herpetic Uveitis With Posterior Segment Involvement.
    Arch Ophthalmol. [Abstract] [Full-text]
18. Highly active antiretroviral therapy-induced immune recovery in an HIV-positive patient with a history of herpes zoster ophthalmicus.
    Optometry. [Abstract] [Full-text]
19. Facial sensibility of patients with trigeminal neuralgias.
    Clin Neurol Neurosurg. [Abstract] [Full-text]
20. Identification of Herpesviruses Types 1 to 8 and Human Papillomavirus in Acute Apical Abscesses.
    J Endod, 37(1): 10-16. [Abstract] [Full-text]
21. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
    Heart Lung. [Abstract] [Full-text]
22. Granulomatous skin lesions complicating Varicella infection in a patient with Rothmund-Thomson syndrome and immune deficiency: case report.
    Orphanet J Rare Dis, 5(1): 37. [Abstract] [Full-text]
23. Clinical research evidence of cupping therapy in China: a systematic literature review.
    BMC Complement Altern Med, 10(1): 70. [Abstract] [Full-text]
24. Upregulation of CXCL10 in Human Dorsal Root Ganglia during Experimental and Natural Varicella-Zoster Virus Infection.
    J Virol, 85(1): 626-631. [Abstract] [Full-text]
25. High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation.
    Biol Blood Marrow Transplant. [Abstract] [Full-text]
26. Corticosteroids for preventing postherpetic neuralgia.
    Cochrane Database Syst Rev, 12: CD005582. [Abstract] [Full-text]
27. Keeping our adult patients healthy and active: the role of vaccines across the lifespan.
    Phys Sportsmed, 38(4): 35-47. [Abstract] [Full-text]
28. Necrotizing and Nonnecrotizing Variants of Herpetic Uveitis With Posterior Segment Involvement.
    Arch Ophthalmol. [Abstract] [Full-text]
29. Highly active antiretroviral therapy-induced immune recovery in an HIV-positive patient with a history of herpes zoster ophthalmicus.
    Optometry. [Abstract] [Full-text]
30. Facial sensibility of patients with trigeminal neuralgias.
    Clin Neurol Neurosurg. [Abstract] [Full-text]
31. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
    Heart Lung. [Abstract] [Full-text]
32. Clinical research evidence of cupping therapy in China: a systematic literature review.
    BMC Complement Altern Med, 10: 70. [Abstract] [Full-text]
33. Corticosteroids for preventing postherpetic neuralgia.
    Cochrane Database Syst Rev, 12: CD005582. [Abstract] [Full-text]
34. Keeping our adult patients healthy and active: the role of vaccines across the lifespan.
    Phys Sportsmed, 38(4): 35-47. [Abstract] [Full-text]
35. Necrotizing and Nonnecrotizing Variants of Herpetic Uveitis With Posterior Segment Involvement.
    Arch Ophthalmol. [Abstract] [Full-text]
36. Highly active antiretroviral therapy-induced immune recovery in an HIV-positive patient with a history of herpes zoster ophthalmicus.
    Optometry. [Abstract] [Full-text]
37. Facial sensibility of patients with trigeminal neuralgias.
    Clin Neurol Neurosurg. [Abstract] [Full-text]
38. Identification of herpesviruses types 1 to 8 and human papillomavirus in acute apical abscesses.
    J Endod, 37(1): 10-6. [Abstract] [Full-text]
39. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
    Heart Lung. [Abstract] [Full-text]
40. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.
    J Virol, 85(1): 626-31. [Abstract] [Full-text]
41. The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3.
    J Virol, 85(1): 568-81. [Abstract] [Full-text]
42. Identification of herpesviruses types 1 to 8 and human papillomavirus in acute apical abscesses.
    J Endod, 37(1): 10-6. [Abstract] [Full-text]
43. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.
    J Virol, 85(1): 626-31. [Abstract] [Full-text]
44. The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3.
    J Virol, 85(1): 568-81. [Abstract] [Full-text]
45. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
    J Virol, 85(1): 98-111. [Abstract] [Full-text]
46. Identification of herpesviruses types 1 to 8 and human papillomavirus in acute apical abscesses.
    J Endod, 37(1): 10-6. [Abstract] [Full-text]
47. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.
    J Virol, 85(1): 626-31. [Abstract] [Full-text]
48. The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3.
    J Virol, 85(1): 568-81. [Abstract] [Full-text]
49. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis.
    J Virol, 85(1): 98-111. [Abstract] [Full-text]
50. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?
    J Oncol Pharm Pract, 16(4): 266-8. [Abstract] [Full-text]
51. Evolution and world-wide distribution of varicella-zoster virus clades.
    Infect Genet Evol, 11(1): 1-10. [Abstract] [Full-text]
52. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?
    J Oncol Pharm Pract, 16(4): 266-8. [Abstract] [Full-text]
53. Evolution and world-wide distribution of varicella-zoster virus clades.
    Infect Genet Evol, 11(1): 1-10. [Abstract] [Full-text]
54. Evolution and world-wide distribution of varicella-zoster virus clades.
    Infect Genet Evol, 11(1): 1-10. [Abstract] [Full-text]
55. VZV Transcriptome in Latently Infected Human Ganglia.
    J Virol. [Abstract] [Full-text]
56. PS1-17: Herpes Zoster in Children.
    Clin Med Res, 8(3): 184. [Abstract] [Full-text]
57. Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine.
    J Infect Dis. [Abstract] [Full-text]
58. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
    Ann Rheum Dis. [Abstract] [Full-text]
59. Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia.
    AIDS Res Ther, 7(1): 46. [Abstract] [Full-text]
60. VZV Transcriptome in Latently Infected Human Ganglia.
    J Virol. [Abstract] [Full-text]
61. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
    Ann Rheum Dis. [Abstract] [Full-text]
62. Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia.
    AIDS Res Ther, 7(1): 46. [Abstract] [Full-text]
63. Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation.
    Nephrol Dial Transplant, 26(1): 365-8. [Abstract] [Full-text]
64. VZV Transcriptome in Latently Infected Human Ganglia.
    J Virol. [Abstract] [Full-text]
65. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
    Ann Rheum Dis. [Abstract] [Full-text]
66. Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation.
    Nephrol Dial Transplant, 26(1): 365-8. [Abstract] [Full-text]
67. Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation.
    Nephrol Dial Transplant, 26(1): 365-8. [Abstract] [Full-text]
68. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
    Drug Resist Updat. [Abstract] [Full-text]
69. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
    Drug Resist Updat. [Abstract] [Full-text]
70. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
    Drug Resist Updat. [Abstract] [Full-text]
71. Calculation of the Anterograde Velocity of Varicella-Zoster Virions in a Human Sciatic Nerve during Shingles.
    J Infect Dis. [Abstract] [Full-text]
72. Granulomatous skin lesions complicating Varicella infection in a patient with Rothmund-Thomson syndrome and immune deficiency: case report.
    Orphanet J Rare Dis, 5: 37. [Abstract] [Full-text]
73. Granulomatous skin lesions complicating Varicella infection in a patient with Rothmund-Thomson syndrome and immune deficiency: case report.
    Orphanet J Rare Dis, 5: 37. [Abstract] [Full-text]

© 2005-2013 Shingles Research Today. All Rights Reserved.